JP2017537684A - 被験者における慢性閉塞性肺疾患(copd)の重症度を評価するための装置及び方法 - Google Patents
被験者における慢性閉塞性肺疾患(copd)の重症度を評価するための装置及び方法 Download PDFInfo
- Publication number
- JP2017537684A JP2017537684A JP2017525057A JP2017525057A JP2017537684A JP 2017537684 A JP2017537684 A JP 2017537684A JP 2017525057 A JP2017525057 A JP 2017525057A JP 2017525057 A JP2017525057 A JP 2017525057A JP 2017537684 A JP2017537684 A JP 2017537684A
- Authority
- JP
- Japan
- Prior art keywords
- subject
- severity
- copd
- measurement
- cough
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 title claims abstract description 139
- 238000000034 method Methods 0.000 title claims abstract description 58
- 238000005259 measurement Methods 0.000 claims abstract description 143
- 206010011224 Cough Diseases 0.000 claims abstract description 115
- 230000000694 effects Effects 0.000 claims abstract description 63
- 230000000241 respiratory effect Effects 0.000 claims abstract description 46
- 230000036387 respiratory rate Effects 0.000 claims abstract description 39
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 32
- 230000005713 exacerbation Effects 0.000 claims description 26
- 206010013975 Dyspnoeas Diseases 0.000 claims description 15
- 230000033001 locomotion Effects 0.000 claims description 14
- 208000000059 Dyspnea Diseases 0.000 claims description 13
- 238000004590 computer program Methods 0.000 claims description 4
- 230000001133 acceleration Effects 0.000 description 20
- 208000013220 shortness of breath Diseases 0.000 description 10
- 210000000038 chest Anatomy 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000012545 processing Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 229940124630 bronchodilator Drugs 0.000 description 6
- 238000007635 classification algorithm Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 238000005265 energy consumption Methods 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 230000004202 respiratory function Effects 0.000 description 5
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 4
- 239000000168 bronchodilator agent Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 230000037081 physical activity Effects 0.000 description 4
- 201000004193 respiratory failure Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003246 corticosteroid Substances 0.000 description 3
- 229960001334 corticosteroids Drugs 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000005021 gait Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000000513 principal component analysis Methods 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000003434 inspiratory effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 230000005586 smoking cessation Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000009798 acute exacerbation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940124748 beta 2 agonist Drugs 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000012085 chronic inflammatory response Effects 0.000 description 1
- 210000003109 clavicle Anatomy 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 229960001888 ipratropium Drugs 0.000 description 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- -1 monitor compliance Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000009531 respiratory rate measurement Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940110309 tiotropium Drugs 0.000 description 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0823—Detecting or evaluating cough events
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1118—Determining activity level
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/113—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb occurring during breathing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0219—Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
Claims (15)
- 被験者の慢性閉塞性肺疾患(COPD)の重症度を評価するための方法であり、前記方法は、
加速度計を用いて、前記被験者の呼吸数、前記被験者の活動レベル、前記被験者の呼吸努力の測定及び前記被験者による咳の重症度若しくは咳嗽力の測定の測定値を決定するステップ、並びに
前記被験者のCOPDの重症度を表すスコアを決定するために、前記呼吸数、前記活動レベル、前記呼吸努力の測定及び前記咳の重症度若しくは咳嗽力の測定の前記測定値を組み合わせるステップ
を有する方法。 - 前記被験者の呼吸数、前記被験者の活動レベル、前記被験者の呼吸努力の測定及び前記被験者による咳の重症度若しくは咳嗽力の測定は、前記加速度計の測定値だけから決定される、請求項1に記載の方法。
- 前記被験者の呼吸数、前記被験者の活動レベル、前記被験者の呼吸努力の測定及び前記被験者による咳の重症度若しくは咳嗽力の測定は、前記加速度計の測定値及び少なくとも1つの追加のセンサの測定値から決定される、請求項1に記載の方法。
- 前記被験者のCOPDの重症度を表すスコアを決定するために前記測定値を組み合わせる前記ステップは、
前記測定値の各々に対するスコアを決定するために、前記呼吸数、前記活動レベル、前記呼吸努力の測定及び前記咳の重症度若しくは咳嗽力の測定の測定値の各々を夫々の重症度の範囲と比較するステップ、並びに
前記被験者のCOPDの重症度を表す前記スコアを決定するために、前記決定したスコアを追加するステップ
を有する請求項1乃至3の何れか一項に記載の方法。 - 前記方法はさらに、
BODE(Body mass index, Obstruction, Dyspnea and Exercise)スコアに対して、前記被験者のCOPDの重症度を表す前記スコアを校正するステップを有する、請求項1乃至4の何れか一項に記載の方法。 - 前記方法はさらに、
増悪の事象の危険性が高いかどうか又は増悪の事象が進行中であるかどうかを判断するために、前記咳の重症度若しくは咳嗽力の測定をしきい値と比較するステップ
を有する請求項1乃至5の何れか一項に記載の方法。 - 前記方法はさらに、
前記被験者が咳をする又は息を切らしているときを検出するステップ、及び
前記被験者が咳をする又は息を切らしているとき、前記測定値を決定するステップ又は前記組み合わせるステップにおける前記測定値の使用を一時的に中断するステップ
を有する請求項1乃至6の何れか一項に記載の方法。 - コンピュータ可読コードがその中に組み込まれているコンピュータ可読媒体を有するコンピュータプログラムプロダクトにおいて、前記コンピュータ可読コードは、適切なコンピュータ又は処理器により実施されると、前記コンピュータ又は処理器が請求項1乃至7の何れか一項に記載の方法を行うように構成される、コンピュータプログラムプロフダクト。
- 被験者の慢性閉塞性肺疾患(COPD)の重症度を評価するための装置であり、前記装置は、
加速度計を用いて、前記被験者の呼吸数、前記被験者の活動レベル、前記被験者の呼吸努力の測定及び前記被験者による咳の重症度若しくは咳嗽力の測定の測定値を決定する、並びに前記被験者のCOPDの重症度を表すスコアを決定するために、前記呼吸数、前記活動レベル、前記呼吸努力の測定及び前記咳の重症度又は咳嗽力の測定の測定値を組み合わせるように構成される制御ユニット
を有する装置。 - 前記制御ユニットは、前記被験者の呼吸数、前記被験者の活動レベル、前記被験者の呼吸努力の測定及び前記被験者による咳の重症度若しくは咳嗽力の測定の測定値を前記加速度計からの測定値だけから決定するように構成される、請求項9に記載の装置。
- 前記装置はさらに、前記加速度計を有する、請求項9又は10に記載の装置。
- 前記装置は、前記加速度計及び少なくとも1つの追加のセンサを有し、前記制御ユニットは、前記被験者の呼吸数、前記被験者の活動レベル、前記被験者の呼吸努力の測定及び前記被験者による咳の重症度若しくは咳嗽力の測定の測定値を、前記加速度計及び前記少なくとも1つの追加のセンサからの測定値から決定するように構成される、請求項9に記載の装置。
- 前記少なくとも1つの追加のセンサは、前記被験者の動き及び/又は位置を測定するためのセンサである、請求項12に記載の装置。
- 前記被験者のCOPDの重症度を評価するためのシステムにおいて、
前記被験者の特徴を測定する加速度計、及び
請求項9又は10に記載の装置
を有するシステム。 - 前記被験者の動き及び/又は位置を測定する前記少なくとも1つの追加のセンサをさらに有する、請求項14に記載のシステム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14192818 | 2014-11-12 | ||
EP14192818.4 | 2014-11-12 | ||
PCT/EP2015/075999 WO2016075054A1 (en) | 2014-11-12 | 2015-11-07 | Apparatus and method for assessing the severity of chronic obstructive pulmonary disease, copd, in a subject |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017537684A true JP2017537684A (ja) | 2017-12-21 |
JP6688793B2 JP6688793B2 (ja) | 2020-04-28 |
Family
ID=51945720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017525057A Active JP6688793B2 (ja) | 2014-11-12 | 2015-11-07 | 被験者における慢性閉塞性肺疾患(copd)の重症度を評価するための装置及びシステムの作動方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20170325717A1 (ja) |
EP (1) | EP3217874B1 (ja) |
JP (1) | JP6688793B2 (ja) |
CN (1) | CN106999097B (ja) |
WO (1) | WO2016075054A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020196323A1 (ja) * | 2019-03-22 | 2020-10-01 | 謙 松田 | プログラム、情報処理方法及び情報処理装置 |
JP7471354B2 (ja) | 2017-10-04 | 2024-04-19 | リシプロカル・ラボズ・コーポレイション(ディービーエー・プロペラ・ヘルス) | 薬剤デバイス監視に基づくプリエンプティブな喘息リスク通知 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3386383A1 (en) * | 2015-12-08 | 2018-10-17 | ResMed Limited | Non-contact diagnosis and monitoring of sleep disorders |
WO2017210053A1 (en) * | 2016-06-01 | 2017-12-07 | Cardiac Pacemakers, Inc. | Systems to detect respiratory diseases using respiratory sounds |
GB2563205A (en) * | 2017-06-01 | 2018-12-12 | Linde Ag | System and method for predicting an acute exacerbation of a patient's health condition |
IT201700078138A1 (it) * | 2017-07-11 | 2019-01-11 | Milano Politecnico | Dispositivo indossabile per il monitoraggio continuo della frequenza respiratoria |
EP3671760A1 (en) * | 2018-12-19 | 2020-06-24 | Linde GmbH | System and method for predicting an exacerbation |
US10702239B1 (en) | 2019-10-21 | 2020-07-07 | Sonavi Labs, Inc. | Predicting characteristics of a future respiratory event, and applications thereof |
US10709353B1 (en) | 2019-10-21 | 2020-07-14 | Sonavi Labs, Inc. | Detecting a respiratory abnormality using a convolution, and applications thereof |
US10716534B1 (en) | 2019-10-21 | 2020-07-21 | Sonavi Labs, Inc. | Base station for a digital stethoscope, and applications thereof |
US10750976B1 (en) * | 2019-10-21 | 2020-08-25 | Sonavi Labs, Inc. | Digital stethoscope for counting coughs, and applications thereof |
US10709414B1 (en) | 2019-10-21 | 2020-07-14 | Sonavi Labs, Inc. | Predicting a respiratory event based on trend information, and applications thereof |
US11468908B2 (en) | 2020-04-15 | 2022-10-11 | Optum, Inc. | Hybrid input machine learning frameworks |
US10902955B1 (en) * | 2020-05-01 | 2021-01-26 | Georgetown University | Detecting COVID-19 using surrogates |
US11793423B2 (en) | 2021-05-03 | 2023-10-24 | Medtronic, Inc. | Cough detection using frontal accelerometer |
CN115394437A (zh) * | 2021-05-25 | 2022-11-25 | 华为技术有限公司 | 一种呼吸系统疾病筛查的方法及相关装置 |
CN115775629B (zh) * | 2023-02-10 | 2023-05-02 | 北京海思瑞格科技有限公司 | 一种术前基于亚极量运动试验评估PPCs风险的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040133079A1 (en) * | 2003-01-02 | 2004-07-08 | Mazar Scott Thomas | System and method for predicting patient health within a patient management system |
JP2011005240A (ja) * | 2009-04-29 | 2011-01-13 | Resmed Ltd | 呼吸機能不全を検出及び治療するための方法、及び装置 |
JP2013514822A (ja) * | 2009-12-19 | 2013-05-02 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Copd増悪予測システム及び方法 |
JP2013514850A (ja) * | 2009-12-21 | 2013-05-02 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Bodeインデックス測定 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009138976A2 (en) * | 2008-05-12 | 2009-11-19 | Earlysense Ltd | Monitoring, predicting and treating clinical episodes |
US20100152600A1 (en) * | 2008-04-03 | 2010-06-17 | Kai Sensors, Inc. | Non-contact physiologic motion sensors and methods for use |
AU2010273546B2 (en) * | 2009-07-15 | 2013-08-29 | Cardiac Pacemakers, Inc. | Physiological vibration detection in an implanted medical device |
EP2553617A2 (en) * | 2010-03-31 | 2013-02-06 | Koninklijke Philips Electronics N.V. | Method and system for optimizing questionnaires |
RU2650586C2 (ru) * | 2011-11-28 | 2018-04-16 | Конинклейке Филипс Н.В. | Система мониторинга состояния здоровья для вычисления общей оценки риска |
EP2637023A1 (en) * | 2012-03-08 | 2013-09-11 | B.R.A.H.M.S GmbH | Prediction of outcome in patients with chronic obstructive pulmonary disease |
CN202723829U (zh) * | 2012-04-06 | 2013-02-13 | 肖遥 | 一种智能咳嗽监测评价系统 |
WO2014130944A1 (en) * | 2013-02-22 | 2014-08-28 | Temple University | Medical condition management method and system |
-
2015
- 2015-11-07 EP EP15791596.8A patent/EP3217874B1/en active Active
- 2015-11-07 CN CN201580061788.XA patent/CN106999097B/zh active Active
- 2015-11-07 JP JP2017525057A patent/JP6688793B2/ja active Active
- 2015-11-07 US US15/525,398 patent/US20170325717A1/en not_active Abandoned
- 2015-11-07 WO PCT/EP2015/075999 patent/WO2016075054A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040133079A1 (en) * | 2003-01-02 | 2004-07-08 | Mazar Scott Thomas | System and method for predicting patient health within a patient management system |
JP2011005240A (ja) * | 2009-04-29 | 2011-01-13 | Resmed Ltd | 呼吸機能不全を検出及び治療するための方法、及び装置 |
JP2013514822A (ja) * | 2009-12-19 | 2013-05-02 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Copd増悪予測システム及び方法 |
JP2013514850A (ja) * | 2009-12-21 | 2013-05-02 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Bodeインデックス測定 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7471354B2 (ja) | 2017-10-04 | 2024-04-19 | リシプロカル・ラボズ・コーポレイション(ディービーエー・プロペラ・ヘルス) | 薬剤デバイス監視に基づくプリエンプティブな喘息リスク通知 |
WO2020196323A1 (ja) * | 2019-03-22 | 2020-10-01 | 謙 松田 | プログラム、情報処理方法及び情報処理装置 |
JPWO2020196323A1 (ja) * | 2019-03-22 | 2021-11-18 | 株式会社Medical Optfellow | プログラム、情報処理方法及び情報処理装置 |
JP7158783B2 (ja) | 2019-03-22 | 2022-10-24 | 株式会社Medical Optfellow | プログラム、情報処理方法及び情報処理装置 |
JP2022188188A (ja) * | 2019-03-22 | 2022-12-20 | 株式会社Medical Optfellow | プログラム、情報処理方法及び情報処理装置 |
JP7321599B2 (ja) | 2019-03-22 | 2023-08-07 | 株式会社Medical Optfellow | プログラム、情報処理方法及び情報処理装置 |
Also Published As
Publication number | Publication date |
---|---|
CN106999097B (zh) | 2021-05-11 |
JP6688793B2 (ja) | 2020-04-28 |
EP3217874A1 (en) | 2017-09-20 |
US20170325717A1 (en) | 2017-11-16 |
EP3217874B1 (en) | 2022-03-09 |
WO2016075054A1 (en) | 2016-05-19 |
CN106999097A (zh) | 2017-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6688793B2 (ja) | 被験者における慢性閉塞性肺疾患(copd)の重症度を評価するための装置及びシステムの作動方法 | |
JP7284782B2 (ja) | 慢性疾患の監視および管理のためのシステムおよび方法 | |
CN102687152B (zh) | Copd恶化预测系统 | |
US20210219925A1 (en) | Apparatus and method for detection of physiological events | |
EP3551061B1 (en) | System for monitoring patients suffering from respiratory disease comprising a portable medical device | |
JP2018531055A6 (ja) | 慢性疾患の監視および管理のためのシステムおよび方法 | |
US9996677B2 (en) | System and method for obtaining an objective measure of dyspnea | |
US20100305466A1 (en) | Incentive spirometry and non-contact pain reduction system | |
US8491493B2 (en) | Asthma status scoring method and system with confidence ratings | |
US20220167856A1 (en) | Lung function monitoring from heart signals | |
CA2963471C (en) | Device and method for assessing respiratory data in a monitored subject | |
KR102379320B1 (ko) | 스트레인 게이지를 이용한 개인 상관계수 기반의 맞춤형 호흡량 측정 장치 및 방법 | |
CN108882883A (zh) | 对副交感自主神经系统和交感自主神经系统的同时和独立活动进行测量、相关和分析的方法和系统 | |
JP6716888B2 (ja) | 呼吸解析装置、呼吸解析方法及びプログラム | |
US20210196194A1 (en) | Unobtrusive symptoms monitoring for allergic asthma patients | |
CN109963497A (zh) | 高级呼吸监视器和系统 | |
KR102379321B1 (ko) | 스트레인 게이지를 이용한 개인 상관계수 기반의 맞춤형 호흡량 측정 시스템 | |
EP3854299A1 (en) | Unobtrusive symptoms monitoring for allergic asthma patients | |
WO2023110992A1 (en) | Generating an indicator of chronic obstructive pulmonary disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180907 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190613 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190730 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190802 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200121 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200214 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20200221 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200317 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200406 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6688793 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |